The recent instability in global supply have highlighted the value of securing essential medications like Ivermectin. Dependence on overseas manufacturers exposes regions to significant vulnerabilities, including shipping delays, expense fluctuations, and even geopolitical concerns. Moving towards domestic procurement of Ivermectin offers a multitu